DACH2 (dachshund family transcription factor 2) is a DNA-binding transcription factor that plays critical roles in development and disease pathogenesis. During embryonic development, DACH2 functions in muscle development through synergistic interactions with EYA2 and SIX1 proteins, forming a conserved regulatory network originally identified in Drosophila eye development 1. DACH2 participates in a positive regulatory feedback loop with PAX3 in developing somites, where it regulates myogenic differentiation prior to expression of myogenic genes 1. The protein is expressed in embryonic nervous tissues, sensory organs, and limbs, with expression patterns similar to DACH1, suggesting partially redundant functions 2. Interestingly, DACH2 knockout mice are viable and fertile with grossly normal eye and brain development, unlike their Drosophila counterparts 3. In disease contexts, DACH2 has emerged as a significant biomarker. High DACH2 expression is associated with poor prognosis in epithelial ovarian cancer, particularly serous carcinomas, and correlates with cisplatin resistance 4. Similarly, DACH2 expression predicts metastasis and poor survival in muscle-invasive urothelial bladder carcinoma 5. DACH2 variants have also been implicated in premature ovarian insufficiency 6 and identified as a potential risk factor for Alzheimer's disease 7.